COLLABORATION TO ASSIST INTELLECTUAL PROPERTY OWNERS IN REALISING HIDDEN VALUE OF PATENTS

Main Menu | News By Date | News By Supplier | News By Category | About Us

COLLABORATION TO ASSIST INTELLECTUAL PROPERTY OWNERS IN REALISING HIDDEN VALUE OF PATENTS
06 October 2006 - BTG

BTG plc, the global technology commercialisation company, today announced a collaboration with Semiconductor Insights, the leader in technical and patent analyses of integrated circuits and structures, to help semiconductor intellectual property owners maximise the return on their investments.

SI brings up-to-the minute product and technology visibility, and technological foresight into key semiconductor markets and technologies. BTG offers over 50 years’ experience in finding, developing and commercialising IP assets in the high-tech sector, and has a world-wide network of relationships with major high-tech companies, plus the resources needed to profitably enforce patents. Together, BTG and SI provide clients with an integrated service that can rapidly assess, develop, and accelerate the realisation of value from those IP opportunities.

Anthony V. Lando, BTG’s Chief Operating Officer commented: “Companies are not maximising the potential of their IP assets, through lack of resources or unclear strategies. Together, BTG and SI can offer companies the expertise and analytical know-how needed to complete this commercialisation cycle, and help companies realise their true revenue potential.” A recent study1 found companies that should generate between 5 and 10 percent of operating income from their IP, were averaging only 0.5 percent. The study found that the main reasons for this are limited resources and capabilities to review IP portfolios, identify opportunities and construct well planned commercialisation efforts.

“IP is increasingly recognised as a source of significant revenue potential, as well as a central consideration in the valuation of technology companies by the investment community” said Dr. Doug Smeaton, President and Chief Executive Officer of Semiconductor Insights. “However, efforts to commercialise IP assets without careful incorporation of technical, market and legal perspectives can greatly increase the risk and reduce the potential of the final outcome. Together, SI and BTG bring all the required elements to optimise licensing results for IP clients.”

BTG and SI have already worked on a host of joint opportunities, including the successful licensing of BTG’s Multilevel Nonvolatile Memory Cell technology to Hitachi, and British Telecommunications’, Electro-absorption Modulator technology. BTG and SI are now formalising this relationship in order to pursue further valuable opportunities.

http://www.btgplc.com

About: BTG
BTG is an intellectual property and technology commercialisation company that operates internationally. BTG creates value by investing in intellectual property and technology development, and in early stage ventures. We realise value through technology licensing, patent assertion and sale of equity investments. Through a multidisciplinary approach, we apply intellectual property and commercial expertise, together with specialist skills in science and technology, to create major product opportunities in the health and high tech sectors. BTG has commercialised important innovations, including Magnetic Resonance Imaging, Multilevel Cell Memory, Campath (alemtuzumab), the first monoclonal antibody treatment for chronic lymphocytic leukaemia, and recombinant Factor IX blood clotting protein. BTG operates through wholly owned subsidiaries BTG International Ltd and BTG International Inc in the UK and USA, respectively.

More News:
  • For October 2006
  • From BTG
  • For Polymer OLED Devices